These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37379708)

  • 1. CD24 blockade as a novel strategy for cancer treatment.
    Wang Y; Yu H; Yu M; Liu H; Zhang B; Wang Y; Zhao S; Xia Q
    Int Immunopharmacol; 2023 Aug; 121():110557. PubMed ID: 37379708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas.
    Salnikov AV; Bretz NP; Perne C; Hazin J; Keller S; Fogel M; Herr I; Schlange T; Moldenhauer G; Altevogt P
    Br J Cancer; 2013 Apr; 108(7):1449-59. PubMed ID: 23511563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.
    Cufi S; Corominas-Faja B; Vazquez-Martin A; Oliveras-Ferraros C; Dorca J; Bosch-Barrera J; Martin-Castillo B; Menendez JA
    Oncotarget; 2012 Apr; 3(4):395-8. PubMed ID: 22565037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
    Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB
    Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.
    Jaggupilli A; Elkord E
    Clin Dev Immunol; 2012; 2012():708036. PubMed ID: 22693526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma.
    Yang CH; Wang HL; Lin YS; Kumar KP; Lin HC; Chang CJ; Lu CC; Huang TT; Martel J; Ojcius DM; Chang YS; Young JD; Lai HC
    PLoS One; 2014; 9(6):e99412. PubMed ID: 24955581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis.
    Burgos-Ojeda D; Wu R; McLean K; Chen YC; Talpaz M; Yoon E; Cho KR; Buckanovich RJ
    Mol Cancer Ther; 2015 Jul; 14(7):1717-27. PubMed ID: 25969154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44+/CD24- breast cancer cells isolated from MCF-7 cultures exhibit enhanced angiogenic properties.
    Sun H; Jia J; Wang X; Ma B; Di L; Song G; Ren J
    Clin Transl Oncol; 2013 Jan; 15(1):46-54. PubMed ID: 22855175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
    Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
    Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
    Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
    Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of CD24 promotes radiation‑ and chemo‑resistance by inducing stemness properties associated with a hybrid E/M state in breast cancer cells.
    Bontemps I; Lallemand C; Biard D; Dechamps N; Kortulewski T; Bourneuf E; Siberchicot C; Boussin F; Chevillard S; Campalans A; Lebeau J
    Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36367190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster of differentiation 24 monoclonal antibody induces apoptosis in the osteosarcoma cells.
    Zhang YH; Wang ZY; Hao FY; Zhang L
    Eur Rev Med Pharmacol Sci; 2014; 18(14):2038-41. PubMed ID: 25027344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD24 protein inducible expression system is an ideal tool to explore the potential of CD24 as an oncogene and a target for immunotherapy in vitro and in vivo.
    Shapira S; Kazanov D; Weisblatt S; Starr A; Arber N; Kraus S
    J Biol Chem; 2011 Nov; 286(47):40548-55. PubMed ID: 21976680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-based targeting of CD24 enhances antitumor effect of cetuximab via attenuating phosphorylation of Src/STAT3.
    Chen Z; Wang T; Tu X; Xie W; He H; Wang M; Zhang J
    Biomed Pharmacother; 2017 Jun; 90():427-436. PubMed ID: 28391164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.
    Gómez-Gallegos AA; Ramírez-Vidal L; Becerril-Rico J; Pérez-Islas E; Hernandez-Peralta ZJ; Toledo-Guzmán ME; García-Carrancá A; Langley E; Hernández-Guerrero A; López-Casillas F; Herrera-Goepfert R; Oñate-Ocaña LF; Ortiz-Sánchez E
    Stem Cell Res Ther; 2023 Feb; 14(1):16. PubMed ID: 36737794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cancer stem cell markers CD24, EPHA1 and CD9 and their correlation with clinical outcome in epithelial ovarian tumours.
    Nagare RP; Sneha S; Sidhanth C; Roopa S; Murhekar K; Shirley S; Swaminathan R; Sridevi V; Ganesan TS
    Cancer Biomark; 2020; 28(3):397-408. PubMed ID: 32224528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44
    Hui D; Chen J; Jiang Y; Pan Y; Zhang Z; Dong M; Shao C
    Exp Cell Res; 2020 May; 390(2):111968. PubMed ID: 32197932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of Notch1 signaling suppresses properties of lung cancer stem cells.
    Cai H; Lu W; Zhang Y; Liu H; Wang Z; Shen Y
    J Cancer Res Ther; 2019; 15(7):1547-1552. PubMed ID: 31939436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of cancer stem cells in human head and neck squamous cell carcinoma.
    Han J; Fujisawa T; Husain SR; Puri RK
    BMC Cancer; 2014 Mar; 14():173. PubMed ID: 24612587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44 and CD24 coordinate the reprogramming of nasopharyngeal carcinoma cells towards a cancer stem cell phenotype through STAT3 activation.
    Shen YA; Wang CY; Chuang HY; Hwang JJ; Chi WH; Shu CH; Ho CY; Li WY; Chen YJ
    Oncotarget; 2016 Sep; 7(36):58351-58366. PubMed ID: 27521216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.